Combined Knockout of RIPK3 and MLKL Reveals Unexpected Outcome in Tissue Injury and Inflammation
Necroptosis, initially identified as a backup cell death program when apoptosis is hindered, is a prominent feature in the etiology and progression of many human diseases, such as ischemic injury and sepsis. Receptor-interacting protein kinase 3 (RIPK3) is the cardinal regulator of this cell death m...
Main Authors: | Caroline Moerke, Florian Bleibaum, Ulrich Kunzendorf, Stefan Krautwald |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-02-01
|
Series: | Frontiers in Cell and Developmental Biology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fcell.2019.00019/full |
Similar Items
-
Leishmania braziliensis Subverts Necroptosis by Modulating RIPK3 Expression
by: Nivea F. Luz, et al.
Published: (2018-09-01) -
Ripk3 signaling regulates HSCs during stress and represses radiation-induced leukemia in mice
by: Breslin, P.S.J, et al.
Published: (2022) -
The Role of the Key Effector of Necroptotic Cell Death, MLKL, in Mouse Models of Disease
by: Emma C. Tovey Crutchfield, et al.
Published: (2021-05-01) -
Necroptosis in Pulmonary Diseases: A New Therapeutic Target
by: Lingling Wang, et al.
Published: (2021-09-01) -
Bypassing drug resistance by triggering necroptosis: recent advances in mechanisms and its therapeutic exploitation in leukemia
by: Xianbo Huang, et al.
Published: (2018-12-01)